Strongest Quarter Ever for Life Sciences Venture Funding
Life sciences venture funding reached an all-time high in the first quarter of 2007, with 36% of total investments going toward the sector. Medical device […]
Blog
When’s the Right Time to Hire a PR Pro?
Jim Weinrebe has been doing healthcare PR and marketing for over 20 years. In his current role as senior vice president at Schwartz Communications, Weinrebe […]
Sights Set on Advancing Treatment for Retinal Disease
A piece from the current issue of The American focuses on three small med tech firms’ efforts to reverse blindness — and the challenges such companies face […]
Evera Gets CE Mark Approval for Lip Implant
Evera Medical (formerly Juva Medical), of Foster City, CA, has received CE Mark approval for a saline-filled implant for facial soft tissue augmentation called FulFil. The […]
Smart Buys: OSI Systems and Viasys Healthcare
In the May issue of SmartMoney, the magazine picks its top-10 stocks for the next 10 years. To make the first cut, companies had to […]
IntriCon Bolsters Medical Business with Tibbetts Acquisition
IntriCon Corporation, an Arden Hills, MN, company that makes miniature medical and electronics products, has agreed to buy privately held Tibbetts Industries for $4.5 million […]
FDA Okays Cepheid’s Test for MSRA
FDA signed off yesterday on a new test for identifying Methicillin-resistant Staphylococcus aureus (MSRA), the leading cause of hospital-acquired infections. The Xpert MSRA test, made […]
Minnesota Firm Raises $8.5 Million for Nanotech Investment
The Minneapolis/St. Paul Business Journal reported yesterday that IFC Medical, a small medical technology company based in Plymouth, MN, has raised $8.5 million to invest in […]
AquaSonix Therapy Hits Hospitals and Rehab Centers
AquaSonix Therapy, a treatment program that combines sound pressure waves with low impact exercise in a warm water pool, is being made available to hospitals, […]
Spirus Medical Raises $8.5 Million
Spirus Medical, a diagnostics company based in Stoughton, MA, has raised $8.5 million in Series B convertible preferred stock financing. BioVentures Investors, Point Judith Capital and Village […]